BlossomHill Therapeutics and Foundation Medicine, Inc. have partnered to develop a companion diagnostic assay for BH-30643. This assay will detect the EGFR C797S resistance mutation, a key challenge in treating non-small cell lung cancer. The collaboration aims to guide the
News
Diagnostics
Innovation
Research
The Research category covers the latest medical studies, breakthroughs, and scientific advancements shaping the future of healthcare.

